All resources

Conflict can arise between health professionals and the parents of children not only where there is disagreement on the withdrawal or withholding of life sustaining treatment but also in more general routine care. In this paper for paediatricians and other health professionals we attempt to suggest ...

In 2017 we responded to the Science and Technology Committee’s inquiry into evidence-based early-years intervention.

Drug allergy is a reaction to a medicinal product. This is one of several allergy care pathways, which tell health professionals what they need to know in order to provide the best care possible.

We address the concerns circulating on social media and reported in the press about the safety of anti-inflammatory medicines such as ibuprofen, diclofenac or naproxen in patients with COVID-19 infection.

In 2018 we responded to the Welsh Government’s draft Bill for Autism. We welcome calls for increased resource to support children with Autism Spectrum Disorder (ASD) and improve outcomes for children with ASD. However, we are concerned about the possible unintended consequences of this proposed legi...

The British Paediatric Surveillance Unit (BPSU) welcomes applications from clinicians and researchers who wish to carry out national surveillance on rare childhood diseases.

Since 2014, we've invited stakeholders from across the rare disease community to this informal networking event. Young people speak about their experiences of living with a rare disease, and patient advocates, researchers and health professionals talk about working in the field. Read on for highligh...

Download monthly reporting instructions for the British Paediatric Surveillance Unit - for each current study, and for previous months.

The UK has one of the lowest rates of breastfeeding in Europe. We strongly support national policies, practices and legislation that are conducive to breastfeeding, as well as promotion, advice and support to new mothers. Our messages and recommendations in this statement are specific to the UK.

The Royal College of Paediatrics and Child Health and British Paediatric Neurology Association has developed this Q&A in light of recent developments in this area. It advises on the legality and safety of cannabis-based products and considers the evidence base for their potential harms and benefits.